These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21933883)

  • 1. Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.
    Jiang ZK; Sato M; Wei LH; Kao C; Wu L
    Cancer Res; 2011 Oct; 71(19):6250-60. PubMed ID: 21933883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionality of androgen receptor-based gene expression imaging in hormone refractory prostate cancer.
    Sato M; Johnson M; Zhang L; Gambhir SS; Carey M; Wu L
    Clin Cancer Res; 2005 May; 11(10):3743-9. PubMed ID: 15897571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.
    Sato M; Figueiredo ML; Burton JB; Johnson M; Chen M; Powell R; Gambhir SS; Carey M; Wu L
    Gene Ther; 2008 Apr; 15(8):583-93. PubMed ID: 18305574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
    Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
    Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel prostate-specific promoter derived from PSA and PSMA enhancers.
    Lee SJ; Kim HS; Yu R; Lee K; Gardner TA; Jung C; Jeng MH; Yeung F; Cheng L; Kao C
    Mol Ther; 2002 Sep; 6(3):415-21. PubMed ID: 12231179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.
    Li X; Zhang YP; Kim HS; Bae KH; Stantz KM; Lee SJ; Jung C; Jiménez JA; Gardner TA; Jeng MH; Kao C
    Cancer Res; 2005 Mar; 65(5):1941-51. PubMed ID: 15753394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-step amplification of the human PPT sequence provides specific gene expression in an immunocompetent murine prostate cancer model.
    Dzojic H; Cheng WS; Essand M
    Cancer Gene Ther; 2007 Mar; 14(3):233-40. PubMed ID: 17053814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular imaging system based on both transcriptional and genomic amplification to detect prostate cancer cells in vivo.
    Pouliot F; Sato M; Jiang ZK; Huyn S; Karanikolas BD; Wu L
    Mol Ther; 2013 Mar; 21(3):554-60. PubMed ID: 23247102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
    Locke JA; Guns ES; Lubik AA; Adomat HH; Hendy SC; Wood CA; Ettinger SL; Gleave ME; Nelson CC
    Cancer Res; 2008 Aug; 68(15):6407-15. PubMed ID: 18676866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
    Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
    Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector.
    Iyer M; Salazar FB; Lewis X; Zhang L; Carey M; Wu L; Gambhir SS
    Mol Ther; 2004 Sep; 10(3):545-52. PubMed ID: 15336654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.
    Decker KF; Zheng D; He Y; Bowman T; Edwards JR; Jia L
    Nucleic Acids Res; 2012 Nov; 40(21):10765-79. PubMed ID: 23019221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen.
    Evans MJ; Smith-Jones PM; Wongvipat J; Navarro V; Kim S; Bander NH; Larson SM; Sawyers CL
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9578-82. PubMed ID: 21606347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
    Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
    Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
    Wu L; Matherly J; Smallwood A; Adams JY; Billick E; Belldegrun A; Carey M
    Gene Ther; 2001 Sep; 8(18):1416-26. PubMed ID: 11571582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.
    Leon CG; Locke JA; Adomat HH; Etinger SL; Twiddy AL; Neumann RD; Nelson CC; Guns ES; Wasan KM
    Prostate; 2010 Mar; 70(4):390-400. PubMed ID: 19866465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
    Suzuki S; Tadakuma T; Asano T; Hayakawa M
    Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.